Lyntero 150 mg Tablet 30's Substitute
Adley Formulations
₹12938
(₹215.63 per unit)
Zydus Healthcare Ltd
₹14057.5
(₹234.29 per unit)
Lucien Life Sciences
₹7031
(₹234.37 per unit)
Natco Pharma Ltd
₹7453
(₹248.43 per unit)
Admac Lifesciences(Oncology)
₹14999
(₹249.98 per unit)
Medion Biotech Pvt Ltd
₹16000
(₹266.67 per unit)
Hetero Healthcare Pvt Ltd
₹8447
(₹281.57 per unit)
Lupin Ltd
₹22875
(₹381.25 per unit)
Samarth Life Sciences Pvt Ltd
₹21093.5
(₹703.12 per unit)
Emcure Pharmaceuticals Ltd
₹45000
(₹750.0 per unit)
Symbion Lifescience
₹46500
(₹775.0 per unit)
Maximal Healthcare Pvt Ltd
₹54000
(₹900.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹25312
(₹904.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹50625
(₹904.02 per unit)
Astra Zeneca Pharma India Ltd
₹41025
(₹5128.13 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Lyntero 150 mg Tablet 30's to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - OLAPARIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Lyntero 150 mg Tablet 30's is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Lyntero 150 mg Tablet 30's are as follows:
Lyntero 150 mg Tablet 30's belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Lyntero 150 mg Tablet 30's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
The substitutes of Lyntero 150 mg Tablet 30's contain the same active salt(s) - OLAPARIB-150MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Lyntero 150 mg Tablet 30's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Lyntero 150 mg Tablet 30's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Lyntero 150 mg Tablet 30's meet the same safety and efficacy standards as Lyntero 150 mg Tablet 30's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Lyntero 150 mg Tablet 30's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Lyntero 150 mg Tablet 30's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Lyntero 150 mg Tablet 30's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Lyntero 150 mg Tablet 30's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Lyntero 150 mg Tablet 30's to its substitute. Always consult your doctor before switching.
Lyntero 150 mg Tablet 30's is used to treat ovarian, breast, pancreatic, and prostate cancers.
Lyntero 150 mg Tablet 30's contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Lyntero 150 mg Tablet 30's.
Yes, Lyntero 150 mg Tablet 30's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.
Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.
Lyntero 150 mg Tablet 30's is not a traditional chemotherapy pill. It's a targeted therapy, also known as a PARP inhibitor, which works differently from chemotherapy.
When taking Lyntero 150 mg Tablet 30's, avoid or limit foods high in grapefruit or grapefruit juice, as these can interact with the medication. Additionally, consult your doctor or pharmacist for personalized dietary advice.
The duration of Lyntero 150 mg Tablet 30's treatment can vary depending on the type of cancer being treated and the patient's response to the medication. Generally, Lyntero 150 mg Tablet 30's is taken until disease progression, unacceptable toxicity, or completion of a specified treatment period. Therefore, follow your doctor's instructions carefully.
Before taking Lyntero 150 mg Tablet 30's, inform your doctor about all your medical conditions, sensitivities, and medications. Also, mention if you're pregnant, planning to become pregnant, or breastfeeding. This will ensure safe use and help avoid any potential interactions.
Lyntero 150 mg Tablet 30's can interact with other medications, so do not use any other medications unless your doctor advises. Your doctor will check for potential interactions and advise you on how to take them safely with Lyntero 150 mg Tablet 30's.
No, Lyntero 150 mg Tablet 30's is not recommended for use during pregnancy and breastfeeding, and it causes unwanted side effects. However, please consult your doctor if you have any concerns.
The common side effects of Lyntero 150 mg Tablet 30's are feeling very tired, pale skin, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Please consult your doctor if any of these side effects persist or worsen.
RX
RX